Tim Brown: A New Framework for Managing Chemotherapy-Induced Thrombocytopenia
Tim Brown and Udhayvir Grewal/LinkedIn

Tim Brown: A New Framework for Managing Chemotherapy-Induced Thrombocytopenia

Tim Brown, GI Medical Oncologist and Assistant Professor at UT Southwestern Medical Center, shared by Udhayvir  Grewal, MD, GI Medical Oncologist and Assistant Professor at Emory University School of Medicine and Winship Cancer Institute, on X:

“TPORAs in GI cancers, out now in Journal of Clinical Oncology
Thanks to Udhayvir Grewal for leading this effort”

Quoting Udhayvir  Grewal:

“Hot off the press! Enjoyed writing this commissioned piece ‘Bridging the Gap’ in Journal of Clinical Oncology on the role of thrombopoeitin receptor agonists for the management of chemotherapy induced thrombocytopenia in GI malignancies; with Raafat Alameddine, Nicholas Hornstein, Tim Brown.

Gut Onc Lab (a commentary on the recently published ACT-GI trial).

We propose a three dimensional framework to guide patient selection.

Title: Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer–Associated Chemotherapy-Induced Thrombocytopenia

Authors: Raafat S. Alameddine, Timothy J. Brown, Nicholas J. Hornstein, Udhayvir S. Grewal

Read The Full Article.

You may also be interested in: Chemotherapy-Induced Kidney Damage: Symptoms, High-Risk Drugs and Prevention

Tim Brown